Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
For the nine months ended September 30, 2026, ConnectM Technology Solutions reported revenues of $26.35 million, an increase from $24.31 million in the prior year. The company recorded a net loss attributable to stockholders of $2.32 million, significantly improved from a $12.18 million loss in 2025, primarily due to a $19.05 million gain on the disposal of discontinued operations.
Host Digital Inc. reported a net loss of $11.45 million for the eight months ended September 30, 2026, following a reverse acquisition and public offering in September 2026. The company generated $1.48 million in net sales during the period, while significantly expanding its balance sheet to $108.2 million in total assets, primarily through intangible assets and right-of-use assets.
Picard Medical, Inc. is a newly public medical device company focused on total artificial heart therapy, reporting 2,661,574 shares outstanding as of November 12, 2026. The filing highlights significant risks including customer concentration, reliance on single-source suppliers, and an explanatory paragraph from its auditors regarding its ability to continue as a going concern.
Cyabra, Inc. reported revenues of $5.27 million for the nine months ended September 30, 2026, compared to $4.08 million in the prior year period. The company experienced a significant net loss of $16.8 million, driven by increased research and development and general administrative expenses following a business combination and PIPE financing.
Omeros reported strong Yard-Temlia momentum with $35.9M net sales and positive operating cash flow, though European regulatory setbacks and a refusal to provide 2027 guidance remain key overhangs.
Soluna is aggressively pivoting from Bitcoin mining to AI data centers, leveraging 109.3 million cash and 2.5 current ratio to fund 1.7 gigawatts of pipeline capacity.
STEM is pivoting to a software-centric model by de-emphasizing low-margin hardware resales, resulting in record margins but triggering a strategic review and going concern warnings.
NextBoat delivered record Q3 revenue of $50.26 million, up 111%, but net losses widened to $4.6 million due to aggressive acquisition integration and inventory management challenges.
Aqua Metals is pivoting to a phased deployment and aggressive cost-cutting to preserve liquidity while navigating policy uncertainty and seeking strategic alternatives.
Corteva Director Gregory R. Page Buys $185K of Stock
Gregory R. Page, Director, bought 20,000 shares of Corteva, Inc. at $9.25 to $9.29 a share (average $9.27) in 2 transactions, worth $185K in total between Nov 13, 2026 and Nov 16, 2026. Shares held after the trade: 20,000 (+100.0%).
Thermo Fisher Scientific President & COO Gianluca Pettiti Sells $2.9M of Stock
Gianluca Pettiti, President & COO, sold 4,133 shares of Thermo Fisher Scientific Inc. at $701.42 a share, worth $2.9M in total on Nov 13, 2026. Shares held after the trade: 22,816 (-14.1%).
Kurt Pletcher, CLO, sold 135 shares of Equinix Inc at $1,041.36 a share, worth $141K in total on Nov 16, 2026. Shares held after the trade: 3,744 (-3.5%).
Orion180 Insurance Group CEO Kenneth Gregg Buys $1.02M of Stock
Kenneth Gregg, CEO, bought 96,150 shares of Orion180 Insurance Group Inc. at $10.66 a share, worth $1.02M in total on Nov 12, 2026. Shares held after the trade: 60,031,410 (+0.2%).
Global Self Storage Chairman and CEO Mark Campbell Winmill Buys $29.1K of Stock
Mark Campbell Winmill, Chairman and CEO, bought 5,947 shares of Global Self Storage, Inc. at $4.90 a share, worth $29.1K in total on Nov 13, 2026. Shares held after the trade: 379,082 (+0.9%).
Corteva CEO Luther C. Kissam IV Buys $300K of Stock
Luther C. Kissam IV, CEO, bought 32,292 shares of Corteva, Inc. at $9.30 a share, worth $300K in total on Nov 13, 2026. Shares held after the trade: 185,379 (+21.1%).
Lightpath Technologies President & CEO Shmuel Rubin Buys $19.2K of Stock
Shmuel Rubin, President & CEO, bought 2,860 shares of Lightpath Technologies Inc at $6.71 a share, worth $19.2K in total on Nov 13, 2026. Shares held after the trade: 286,073 (+1.0%).
NovelStem International Corp. reported a net loss of $225,105 for the nine months ended September 30, 2026, compared to a net income of $2,469,177 in the prior year period which was driven by one-time debt relief and investment disposal gains. The company continues to operate with a significant shareholders' deficit of $2.1 million and requires additional financing to sustain operations following the liquidation of its primary equity investment, NewStem.
The filing highlights significant volatility in natural gas and helium markets, noting that Henry Hub spot prices fluctuated between $2.54 and $30.72 per MMBtu in early 2026. Renergen faces substantial liquidity risks related to its debt covenants and capital expenditure requirements for Phase 2 expansion, while global helium supply remains constrained with spot prices exceeding $2,000/Mcf due to geopolitical disruptions.
Hydrofarm Holdings Group reported a significant decline in net sales to $14.5 million for the third quarter of 2026 compared to $29.4 million in the prior year, driven by industry oversupply and customer pricing pressures. The company recorded a net loss for the nine-month period of $33.0 million and reported a total stockholders' deficit of $93.9 million, raising concerns about its ability to continue as a going concern.
iBio announced extended preclinical data from a non-human primate study of IBIO-610, showing a 2.3% reduction in body weight and significant fat mass reduction over 28 weeks while maintaining lean mass. The company also disclosed preclinical data for its amylin program demonstrating selective receptor activation and reduced food intake in rat models. These results highlight the efficacy of iBio's AI-enabled antibody discovery platform in targeting obesity and cardiometabolic diseases.
Traws Pharma reported Q3 2026 financial results and provided clinical updates for its COVID-19 and influenza antiviral programs. The company highlighted positive Phase 2a results for ratutrelvir and plans to engage the FDA on a registration strategy for PAXLOVID-ineligible patients.
Term
Q3 2026
“We have made meaningful progress toward our goal of developing new treatment and prevention options for patients most vulnerable to serious respiratory viral diseases.”
Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma
“For tivoxavir marboxil, the tablet bridging study achieved its objectives, and toxicology retesting is complete. These results support further evaluation of TXM as a potential once-monthly oral influenza prevention option. We expect to resubmit the updated toxicology package in the fourth quarter.”
Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma
Bridger Aerospace Group Holdings Financial Results
Bridger Aerospace reported third quarter 2026 revenue of $56.7 million, a 13% increase compared to the prior year period. The company announced a strategic review of alternatives to refocus on core aerial services and high-margin business lines. Additionally, the company reported a net loss of $1.8 million for the quarter, an improvement from a $13.4 million net loss in Q3 2025.
Toppoint Holdings reported Q3 2026 revenue of $4.5 million and a net loss of $0.09 million, a significant improvement from the $4.15 million loss in the prior-year period. The company also announced a one-for-five reverse stock split effective November 23, 2026, following a trading halt by NYSE American due to low share price.
Arrive AI Inc. implemented a 1-for-48 reverse stock split of its common stock effective November 12, 2026. The action reduced the number of outstanding shares from approximately 68.8 million to 1.4 million to increase the per-share trading price and regain compliance with Nasdaq's $1.00 minimum bid price requirement.
AMC Robotics reported Q3 2026 revenue of $0.97 million, a 3.1% sequential increase driven by product sales growth. The company is prioritizing its Kyro quadruped robotic platform for security and inspection markets while remaining on track to commission its Vietnam manufacturing facility by year-end 2026.
Term
Q3 2026
“During the quarter, we sharpened our strategic focus on advancing Kyro, our quadruped robotic platform, toward commercialization, prioritizing opportunities in security, surveillance and inspection markets.”
Sean Da, Chairman of the Board and CEO of AMC Robotics
“The appointment of Dr. Ang Li as Chief Technology Officer further strengthens our ability to accelerate product development and bring more advanced autonomous capabilities to market, while continued progress at our Vietnam manufacturing facility keeps us on track towards initial trial production in early 2027.”
Sean Da, Chairman of the Board and CEO of AMC Robotics
Century Casinos announced that its financial statements for fiscal years 2024 and 2025, and the first two quarters of 2026, should no longer be relied upon due to accounting errors. The misstatement relates to the accounting for a 50% interest in Smooth Bourbon, LLC, which owns the real estate for the Nugget Casino Resort. The company expects to report at least one material weakness in its internal control over financial reporting as a result of the restatement.
DNA X, Inc. approved a substitute cash award for acting CEO and Executive Chairman Mike Mulica in lieu of an annual RSU grant due to a lack of available shares in the company's equity incentive plan. The award is valued at $50,000 worth of 'Phantom RSUs' as of November 14, 2026, and will be settled in cash upon vesting at the 2027 annual meeting or a change in control.
Cable One received a deficiency notice from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement. The company has 45 days to submit a plan to regain compliance within an 18-month cure period. Additionally, the company disclosed it missed a $10 million interest payment on its 4.00% senior notes due 2030, entering a 30-day grace period.
Greenlane Holdings appointed Peter Kampian as the chair of its Audit Committee, effective November 11, 2026. Mr. Kampian succeeds Bruce Linton, who will remain a member of the committee. This filing amends a previous report from October 2026 regarding Mr. Kampian's initial appointment to the Board of Directors.
Enova International $365M Debt Financing with Truist Bank
Enova International's subsidiary, Receivable Assets of OnDeck, LLC (RAOD), entered into a thirteenth amendment to its existing asset-backed revolving debt facility. The amendment sets the total facility commitment at approximately $365.1 million, consisting of Class A and Class B revolving loans, and extends the revolving period to November 2028 with a final maturity in November 2029.